Phase 4 Psoriasis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
"Who might be able to join this trial:
- You must be an adult aged 18 or older (male or female)
- You must have been diagnosed with chronic plaque psoriasis (a common form of psoriasis that causes raised, scaly patches on the skin)
- Your psoriasis must be affecting between 2% and 10% of your body surface area
- You must have been receiving a biologic therapy (a type of medication that targets specific parts of the immune system) for at least 24 weeks
- You must be willing and able to sign a consent form before taking part in any study activities
Who may not be able to join:
- Your psoriasis affects less than 2% or more than 10% of your body surface area
- You are not currently taking a biologic medication, or you have been taking one for less than 24 weeks
- You have used any topical (applied to the skin) psoriasis treatment within the 14 days before your first study visit
- You have previously used a medication called DUOBRII
Important: Always verify eligibility with the trial site directly before applying."
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 6094434500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Body surface area improvement
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.